Max Orelus
Impact in
- Rheumatology top 5%
- Osteoarthritis Treatment and Mechanisms
- Genetics top 5%
- Genetic Associations and Epidemiology
- Genomics and Rare Diseases
- Connective tissue disorders research
Papers in
- Genetics 10
- Genetic Associations and Epidemiology 9
- Genomics and Rare Diseases 3
- BRCA gene mutations in cancer 1
-
- Blood Coagulation and Thrombosis Mechanisms 4
Max Orelus
18 papers receiving 1.1k citations
Max Orelus's Hit Papers
Peers
Comparison fields: 5 of 83
- Rheumatology 251
- Genetics 471
- Internal Medicine 19
- Infectious Diseases 91
- Hematology 65
Countries citing papers authored by Max Orelus
This map shows the geographic impact of Max Orelus's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Max Orelus with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Max Orelus more than expected).
Fields of papers citing papers by Max Orelus
This network shows the impact of papers produced by Max Orelus. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Max Orelus. The network helps show where Max Orelus may publish in the future.
No co-authors to show.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Deciphering osteoarthritis genetics across 826,690 individuals from 9 populations Hit paper breakdown → | 2021 | 334 |
| 2 | Advancing human genetics research and drug discovery through exome sequencing of the UK Biobank Hit paper breakdown → | 2021 | 270 |
| 3 | Genome-wide analysis provides genetic evidence that ACE2 influences COVID-19 risk and yields risk scores associated with severe disease Hit paper breakdown → | 2022 | 139 |
| 4 | 2022 | 106 | |
| 5 | 2022 | 43 | |
| 6 | 2021 | 27 | |
| 7 | 2022 | 23 | |
| 8 | 2022 | 21 | |
| 9 | 2025 | 15 | |
| 10 | 2022 | 13 | |
| 11 | 2023 | 11 | |
| 12 | 2023 | 11 | |
| 13 | 2022 | 10 | |
| 14 | 2021 | 9 | |
| 15 | 2022 | 9 | |
| 16 | 2025 | 9 | |
| 17 | 2022 | 8 | |
| 18 | 2022 | 7 |
About Max Orelus
Max Orelus is a scholar working on Genetics, Hematology, Infectious Diseases, Internal Medicine and Sensory Systems, having authored 18 papers that have together received 1.1k indexed citations. Recurring topics across this work include Genetic Associations and Epidemiology (9 papers), Blood Coagulation and Thrombosis Mechanisms (4 papers), Genomics and Rare Diseases (3 papers), Cardiac electrophysiology and arrhythmias (2 papers), SARS-CoV-2 and COVID-19 Research (2 papers), BRCA gene mutations in cancer (1 paper), Venous Thromboembolism Diagnosis and Management (1 paper) and Glaucoma and retinal disorders (1 paper). The work is most often cited by research in Rheumatology (251 citations), Genetics (471 citations), Internal Medicine (19 citations), Infectious Diseases (91 citations) and Hematology (65 citations). Max Orelus has collaborated with scholars based in United States, Sweden and United Kingdom. Their work appears in journals such as Nature Genetics, Journal of the American Heart Association, Communications Biology, Scientific Reports and Cell.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.